SNY:NASDAQ
Sanofi SA
40,07 $
arrow_downward
−0,40%(−0,16) 1 p
40,30 $
arrow_upward
+0,57% (+0,23)todayEnne avanemist
Suletud: 9. okt, 16:00:00 GMT −4 · USD
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SNY põhistatistika genereerimine…
Ava
40,17 $
Kõrge
40,30 $
Madal
39,92 $
Turu kapit.
95,52 mld
Keskm. maht
2,77 mln
Maht
230,00
Dividend
6,04%
Kvartaalne dividend
0,60 $
Dividendikuupäev
5. mai 2026
Hinna ja tulu suhe
21,94
52 näd kõrgeim
52,68 $
52 näd madalaim
39,18 $
Aktsiatulu
1,83 $
Beeta
0,37
Käibivad aktsiad
2,42 mld
Töötajate arv
75 tuh
Ava
40,17 $
Kõrge
40,30 $
Madal
39,92 $
Turu kapit.
95,52 mld
Keskm. maht
2,77 mln
Maht
230,00
Dividend
6,04%
Kvartaalne dividend
0,60 $
Dividendikuupäev
5. mai 2026
Hinna ja tulu suhe
21,94
52 näd kõrgeim
52,68 $
52 näd madalaim
39,18 $
Aktsiatulu
1,83 $
Beeta
0,37
Käibivad aktsiad
2,42 mld
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
AD HOC NEWS
·
2 päeva eest
Jefferies keeps Buy rating for Sanofi stock at EUR 100 target
Profiil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Teave üksuse Sanofi SA kohta
TegevjuhtBelén Garijo | Paul Hudson
Töötajad74,8 tuh
Asutatud1973
PeakontoridPariis, Île-de-France, Prantsusmaa
Sektor-
Veebisaitsanofi.com